Australia Liver Cancer Diagnostics Market Size & Outlook
Australia liver cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Australia liver cancer diagnostics market highlights
- The Australia liver cancer diagnostics market generated a revenue of USD 74.9 million in 2023 and is expected to reach USD 125.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
- In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
- Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.
Liver cancer diagnostics market data book summary
| Market revenue in 2023 | USD 74.9 million |
| Market revenue in 2030 | USD 125.9 million |
| Growth rate | 7.7% (CAGR from 2023 to 2030) |
| Largest segment | Outpatient facilities |
| Fastest growing segment | Home Care |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche Holding AG ADR, Qiagen NV, Siemens Healthineers AG ADR, Becton Dickinson & Co, Illumina Inc, Epigenomics AG, Koninklijke Philips NV, FUJIFILM Holdings Corp |
Other key industry trends
- In terms of revenue, Australia accounted for 1.3% of the global liver cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan liver cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 209.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Liver Cancer Diagnostics Market Scope
Liver Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia liver cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liver cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 61.55% in 2023. Horizon Databook has segmented the Australia liver cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Rise in initiatives undertaken by the research academies and institutes to enhance research related to early diagnosis of liver cancer is one of the major factors influencing the market growth in the near future. For instance, in July 2020, a research center worth USD 10.8 million was established for liver cancer research.
This included USD 5 million Cancer Research Trust grant and USD 5.8 million from the Curtin University, Minderoo Foundation, Harry Perkins Institute of Medical Research, The University of Western Australia and the State Government as well as other charitable organizations present in Australia. The rate of primary liver cancer is increasing gradually by 4-5% every year.
Reasons to subscribe to Australia liver cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia liver cancer diagnostics market databook
-
Our clientele includes a mix of liver cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia liver cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia liver cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia liver cancer diagnostics market size, by end use, 2018-2030 (US$M)
Australia Liver Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
